Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue

Axonics, Inc. , a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported preliminary unaudited...

Related Keywords

Boston ,Massachusetts ,United States ,Raymondw Cohen , ,Axonics Inc ,Axonic Investor Relations Department ,Boston Scientific Corporation ,Exchange Commission ,Nasdaq ,Party Transactions ,Axonic Investor Relations ,Axonic Definitive Proxy Statement ,Certain Beneficial Owners ,Executive Officers ,Axonic Current Report ,Definitive Proxy Statement ,Initial Statement ,Beneficial Ownership ,Annual Statement ,Securities Litigation Reform Act ,Axonic Annual Report ,Axonic Quarterly Report ,Markets ,